Asthma Drugs Caution on Psychiatric Problems
Asthma Drugs to Bear Caution. Singulair (montelukast ) and other asthma medications known as leukotriene modifiers will carry a new precaution about their association with neuropsychiatric events, the Food & Drug Administration (FDA) has announced. According to the agency, it has received reports of agitation, … [Read more...] about Asthma Drugs Caution on Psychiatric Problems
Singulair Safety Review
Singulair Safety Review. Federal regulators said today that they are continuing a probe into the psychiatric side effects of Singulair and similar asthma drugs. The Food & Drug Administration (FDA) began looking into the drugs' potential psychiatric side effects last March, after it received several reports of suicidal behavior in … [Read more...] about Singulair Safety Review
Top Asthma Drugs Get Stronger Warning
Asthma Drugs Strongest Warnings. The asthma medication Advair and Serevent will now carry the strongest warnings the FDA can require of prescription drugs. The "black-box" warnings on both drugs caution that key ingredient salmeterol may increase the risk of asthma-related death. The revised warning cautions that Advair should … [Read more...] about Top Asthma Drugs Get Stronger Warning
FDA Orders
FDA Cleared Asthma Drugs. The US Food and Drug Administration has cleared asthma drugs Advair and Serevent, allowing them to stay on the market as long as warning labels clearly alert patients to potential risks. Made by GlaxoSmithKline, the medications contain salmeterol, a bronchodilator known as a beta2-agonist. It … [Read more...] about FDA Orders
